COMMUNIQUÉS West-GlobeNewswire

RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System
05/12/2024
Over Ten Medical Institutions Nationwide have Initiated RenovoCath Purchase Process, Further Accelerating Commercialization Strategy RenovoRx Estimates Initial Target Market Size for RenovoCath of Several Hundred [...]
Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease
05/12/2024
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing in a global Phase 2a clinical study, BEACON, of the investigational drug [...]
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting
05/12/2024
Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the Fovea Region Critical for Visual Acuity Pivotal Phase 3 ARCHER [...]
Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering
04/12/2024
Jupiter, Florida, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a pipeline targeting [...]
Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study
04/12/2024
BIZENGRI ® is the first and only therapy approved by the FDA specifically for pancreatic adenocarcinoma and NSCLC that harbor NRG1 gene fusions and are advanced unresectable or metastatic 1 Merus and Partner [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
04/12/2024
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 04 déc. 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Monthly information on share capital and company voting rights
04/12/2024
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/12/2024
RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted five newly-hired [...]
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
04/12/2024
PONTE VEDRA, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
DLH Reports Fiscal 2024 Fourth Quarter Results
04/12/2024
Debt Reduced to Under $155 Million as Company Continues its Technology Transformation ATLANTA, Dec. 04, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science [...]
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
04/12/2024
IRVINE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI™ assay. In a paper recently [...]
Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Modulate Tumor Immunity
04/12/2024
Data published in peer-reviewed npj Drug Discovery, a Nature portfolio journal BURLINGAME, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical [...]
Prenetics Announces Participation in December Investor Conferences
04/12/2024
CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team [...]
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
04/12/2024
BANNOCKBURN, Ill., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will [...]
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting
04/12/2024
RNS System to be featured in over 70 scientific presentations and posters Pre-book a demonstration in the NeuroPace Tech Suite to see the latest innovations of the RNS System which simplify the treatment experience for [...]
Acutus Medical Announces Operational Downsizing
04/12/2024
CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and operational downsizing. Dr. Shaden Marzouk, Chairperson [...]
Spineway carries out a capital reduction by reducing the par value of its shares
04/12/2024
Press release Ecully, December 4, 2024 – 8 p.m. CET Spineway carries out a capital reduction by reducing the par value of its shares The Spineway Group, a specialist in innovative implants for the treatment of severe [...]
SPINEWAY procède à une réduction de capital social par diminution de la valeur nominale de l’action
04/12/2024
Communiqué de presse Ecully, le 4 décembre 2024 – 20h Spineway procède à une réduction de capital social par diminution de la valeur nominale de l’action Le groupe Spineway, spécialiste des implants innovants pour le [...]
Milestone Scientific to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
04/12/2024
ROSELAND, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that [...]

Pages